NCT07169474 Treatment of Peritrapezial Osteoarthritis With Isolated Trapeziometacarpal Arthroplasty in 300 Patients
| NCT ID | NCT07169474 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique Saint Jean, France |
| Condition | Trapeziometacarpal Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-09-09 |
| Primary Completion | 2027-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-09-09 with a primary completion date of 2027-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical trial is to assess the functional outcomes of isolated trapeziometacarpal joint arthroplasty in adult patients requiring surgical management of trapeziometacarpal osteoarthritis, with or without associated symptoms. The primary endpoint is the evolution of the Quick DASH functional score between inclusion (preoperative) and one year postoperatively. The study design is a follow-up study of a multicenter cohort.
Eligibility Criteria
Inclusion Criteria:- Patients over 18 years of age who are members or beneficiaries of french social security * Patient requiring surgical management * Clinical and radiographic diagnosis of peri-trapezial osteoarthritis in the 1 or 2 joints: TM osteoarthritis: glickel sign + grinding test STT osteoarthritis: pain on wrist mobilization in flexion-extension and prono-supination * TM (Eaton-Littler stages II to III) and STT (Crosby stages II and III) radiographic osteoarthritis * Persistent pain and functional limitations despite conservative treatment for at least 6 months (combining intermittent immobilization of wrist and thumb + joint infiltration of the 2 joints) * Ability to understand and sign the informed consent form. Exclusion Criteria: * History of surgery on the affected thumb. * Systemic inflammatory diseases (e.g. rheumatoid arthritis). * Active infection or history of joint infection of the upper limb. * Inability to participate in post-operative follow-up.
Contact & Investigator
benjamin Degeorge
PRINCIPAL INVESTIGATOR
Clinique Saint jean sud de france
Frequently Asked Questions
Who can join the NCT07169474 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trapeziometacarpal Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07169474 currently recruiting?
Yes, NCT07169474 is actively recruiting participants. Contact the research team at cecile.spirito@capsante.fr for enrollment information.
Where is the NCT07169474 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT07169474 clinical trial?
NCT07169474 is sponsored by Clinique Saint Jean, France. The principal investigator is benjamin Degeorge at Clinique Saint jean sud de france. The trial plans to enroll 300 participants.